Representing the developed world, the United States will maintain a 2.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$102.6 Million to the region's size and clout in the next 5 to 6 years. Over US$31.4 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, X-ray/Computed Tomography (CT) will reach a market size of US$171.1 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 5% over the next couple of years and add approximately US$94.4 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include among others:
- AMAG Pharmaceuticals, Inc.
- Bayer AG
- Daiichi Sankyo Co., Ltd.
- GE Healthcare
- Guerbet Group
- Starpharma Holdings Limited
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Prevalence of Chronic Diseases Among the Growing Global Population Pushes Up the Diagnostic Burden & Demand for Imaging
Rising Prevalence of Chronic Diseases Amplifies the Volume of Imaging Procedures, Driving Opportunities for Imaging Agents: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
The US$ 37 Billion Robustly Growing Medical Imaging Market Provides Lucrative Opportunities for Contrast Agents for Advanced Visualization: Global Medical Imaging Market (In US$ Billion) for the Years 2018, 2020 and 2022
Aging Population, a Demographic Catalyst Driving Demand for Imaging Services
Rapidly Aging Population & the Challenges Associated With Geriatric Imaging Spurs Demand for Contrast Imaging Agents: Global Population of 65+ Individuals (In 000s) by Region for the Years 2015, 2020 & 2025
Rise of Nuclear Medicine, the Cornerstone for the Growth for Radioactive Tracers
Improving Quality & Value of Nuclear Medicine Bodes Well for Radioactive Contrast Agents: Global Market for Nuclear Imaging (US$ Billion) for the Years 2018, 2020, 2022 and 2025 by Type
Short Supply of Technetium-99m Threatens to Impact Nuclear Imaging Services
Plagued by the Risk of Reactor Decommissioning & Unplanned Maintenance Shutdowns, Fragile Supply of Mo-99 Will Remain a Cause for Concern: Global Mo-99 Production Capacity (In Curies (Ci) Per Week) by Producer for the Years 2016 through 2022
2. FOCUS ON SELECT PLAYERS
AMAG Pharmaceuticals, Inc. (USA)
Bayer Healthcare LLC (USA)
Bracco Imaging SpA (Italy)
GE Healthcare (USA)
Genovis AB (Sweden)
Guerbet Group (France)
J.B. Chemicals & Pharmaceuticals Ltd. (India)
Jodas Expoim (India)
Lantheus Medical Imaging, Inc. (USA)
Magnus Health (India)
Medtronic Plc. (Ireland)
nanoPET Pharma GmbH (Germany)
Sanochemia Pharmazeutika AG (Austria)
Spago Nanomedical AB (Sweden)
Taejoon Pharm Co., Ltd. (South Korea)
Unijules Life Sciences Ltd. (India)
3. MARKET TRENDS & DRIVERS
Migration to Value Based Care Throws the Focus on Quality & Value of Imaging & Its Ability to Improve Patient Care by Providing Better Quality Images
With “Value” being the new Currency in Healthcare Markets Worldwide, Value Based Imaging Will Positively Impact Contrast Enhanced Imaging Procedures: % of Value-Based Reimbursement (VBR) & Fee-For-Service Structured Healthcare Organizations for the Years 2016, 2018 and 2022
Growing Preference for Non-Ionizing Radiation-Based Radioimaging Drives Demand for Contrast Enhanced MRI
Commercially Available MRI Contrast Agents
Spurred by Safety & Efficiency Benefits, Growing MRI Procedures & Parallel Increase in MRI Machines to Benefit Demand for MRI Contrast Agents: Global MRI Equipment Market (In US$ Billion) for the Years 2018, 2020, 2022 and 2024
Equipment Density Correlates With Number of Imaging Procedures: Magnetic Resonance Imaging (MRI) Units in Select Countries (Per Million Population) for the Year 2019
Evolving Clinical Applications of Contrast-Enhanced Ultrasound (CEUS) Drive Demandfor Ultrasound Contrast Agents
Clinically Available Ultrasound Contrast Agents
Growing Use of CEUS in Emergency and Critical Care
Special Focus on Microbubble Contrast Agents for Ultrasound Imaging
Clinical Applications of Microbubbles
Oscillating Microbubbles: To Revolutionize Ultrasound
Growing Market for Ultrasound Equipment Pushes Up the Number of CEUS Procedures Performed: Global Market for Ultrasound Equipment (In US Billion) for the Years 2017, 2019, 2022 and 2024
Continued Value of CT Imaging in Cardiology Despite Risk of Radiation Exposure Drives Demand for Contrast-Enhanced CT
Contrast Agents Used in CT Imaging by Class: A Snapshot
CCTA Gaining Traction in Coronary Arteries Imaging
List of Iodine-Containing Contrast Agents for Coronary CT Angiography
Growing Access to CT Imaging Bodes Well for CT Contrast Agents: Density of CT Scanners in Select Countries (Per Million Population) for the Year 2019
Rise in Image Guided Surgeries Drives Demand for Contrast Agents
Emergence of Molecular-Targeted Fluorescent Tracers
Select Potential “always-on” Targeted Tracers for Fluorescence Image-Guided Surgery (FIGS)
The Use of Gold Nanoclusters as Contrast Agent for IGS of Head and Neck Tumors
Better Surgical Outcome Drives the Number of Image Guided Surgeries Performed Worldwide Along with Demand for Contrast Agents: Global Market for Image Guided Surgical Devices (In US$ Billion) for the Years 2018, 2020, and 2022 by Imaging Type
Stringent Guidelines & Implementation of Best Practices for Safe Use of Contrast Agents to Encourage Patient Acceptance of Contrast Enhanced Imaging
Safety Issues with Iodinated Agents, Gadolinium BCA and Microbubbles
Symptoms of Reaction to Administration of Iodinated Contrast Media Agents
Innovations Remain Crucial to Growth
A Review of Advancements in Contrast Media Injector Technology
Development of New Contrast Agents
Key Challenges Confront the Market
Advances in Imaging Technology Reduce Contrast Media Use
Product Recalls and Side Effects of Contrast Media Challenge Growth
A Snapshot of Side Effects, Allergic and Adverse Reactions with Contrast Agents
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
REST OF EUROPE
REST OF ASIA-PACIFIC
REST OF LATIN AMERICA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
ALLEX MEDICAL SYSTEMS
AMAG PHARMACEUTICALS, INC.
ASCELIA PHARMA AB
BAYER AG - PHARMACEUTICALS
BAYER HEALTHCARE LLC - RADIOLOGY DIVISION
BEIJING BEILU PHARMACEUTICALCO., LTD.
BRACCO IMAGING SPA
BRACCO DIAGNOSTICS, INC.
DONG KOOK LIFESCIENCE
FUJI PHARMA CO., LTD.
FUJIFILM TOYAMA CHEMICAL CO., LTD.
FUJIFILM VISUALSONICS INC.
HANA PHARM CO., LTD.
IMAX DIAGNOSTIC IMAGING LTD.
INTERPHARMA PRAHA, A.S.
J.B. CHEMICALS & PHARMACEUTICALS LTD.
JODAS EXPOIM PVT. LTD.
NOVALEK PHARMACEUTICALS PVT. LTD.
LANTHEUS MEDICAL IMAGING INC.
LIGAND PHARMACEUTICALS, INC.
LIVEALTH BIOPHARMA PVT LTD.
MAGNUS HEALTH MANAGEMENT PVT. LTD.
NANO THERAPEUTICS PVT LTD.
NANOPET PHARMA GMBH
SANOCHEMIA PHARMAZEUTIKA AG
SHANGHAI XUDONG HAIPU PHARMACEUTICAL CO., LTD.
SPAGO NANOMEDICAL AB
STARPHARMA HOLDINGS LTD.
SUBHRA PHARMA PRIVATE, LTD.
TAEJOON PHARMACEUTICAL CO., LTD.
KIRAN MEDICAL SYSTEMS
ULRICH GMBH & CO. KG
UNIJULES LIFE SCIENCES LTD.
YANGTZE RIVER PHARMACEUTICAL GROUP
- Allex Medical Systems
- Amag Pharmaceuticals, Inc.
- Ascelia Pharma Ab
- Bayer Ag - Pharmaceuticals
- Bayer Healthcare LLC
- Beijing Beilu Pharmaceuticalco., Ltd.
- Bipso Gmbh
- Bracco Diagnostics, Inc.
- Bracco Imaging Spa
- Dong Kook Lifescience
- Fuji Pharma Co., Ltd.
- Fujifilm Toyama Chemical Co., Ltd.
- Fujifilm Visualsonics Inc.
- Ge Healthcare
- Genovis Ab
- Guerbet Llc
- Hana Pharm Co., Ltd.
- Imax Diagnostic Imaging Ltd.
- Innopharmax, Inc.
- Interpharma Praha, A.S.
- J.B. Chemicals & Pharmaceuticals Ltd.
- Jodas Expoim
- Kiran Medical Systems
- Lantheus Medical Imaging Inc.
- Ligand Pharmaceuticals, Inc.
- Livealth Biopharma Pvt Ltd.
- M.Biotech Limited
- Magnus Health Management Pvt. Ltd.
- Medtronic Plc.
- Nano Therapeutics Pvt Ltd.
- nanoPET Pharma GmbH
- Novalek Pharmaceuticals Pvt. Ltd.
- Sanochemia Pharmazeutika Ag
- Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
- Spago Nanomedical Ab
- Starpharma Holdings Ltd.
- Subhra Pharma Private, Ltd.
- Taejoon Pharmaceutical Co., Ltd.
- Trivitron Healthcare
- Ulrich Gmbh & Co. Kg
- Unijules Life Sciences Ltd.
- Yangtze River Pharmaceutical Group